This federal contract award, valued at $1,831.58, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026.
The contract covers the delivery of REXULTI 0.5 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit organization that specializes in distributing a comprehensive range of pharmaceutical products, medical supplies, and equipment to federal government agencies, particularly within military and veterans' healthcare systems.
Generated 3/30/25, 12:49 AM